HER2+ and triple-negative breast cancer (TNBC) are known to be more immunogenic than luminal type, and are associated with higher rates of cell proliferation and genomic instability, as well as augmented tumour-infiltrating lymphocytes (TIL) levels [4]. The gene discussed is ERBB2; the disease is neoplasm.